CD34-selected stem cell boost as therapy for late graft rejection following allogeneic transplantation for sickle cell disease

被引：4
|
作者：
Rangarajan, Hemalatha G. [1 ]
Crowell, Sara A. [1 ]
Towerman, Alison S. [2 ]
Shenoy, Shalini S. [2 ]
机构：
[1] Nationwide Childrens Hosp, Dept Pediat Hematol Oncol Blood & Marrow Transpla, Columbus, OH 43205 USA
[2] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA
来源：
BONE MARROW TRANSPLANTATION | 2022年 / 57卷 / 10期
关键词：
MARROW-TRANSPLANTATION; CHIMERISM; OUTCOMES; CHILDREN;
D O I：
10.1038/s41409-022-01749-9
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：1592 / 1594
页数：3
相关论文
共 50 条
  • [31] CD34-Selected, T Cell-Depleted Alternative Donor Stem cell Transplantation For Children
    Gilman, Andrew
    Eckrich, Michael
    Epstein, Stacy
    Barnhart, Carrie
    Oesterheld, Javier
    Grochowski, Darci
    Fukes, Tracy
    Lacaria, Maria
    Cannon, Mark
    BLOOD, 2013, 122 (21)
  • [32] CD34±selected stem cell boost without further conditioning for poor graft function after allogeneic stem cell transplantation in patients with haematological malignancies
    Klyuchnikov, E.
    El-Cheikh, J.
    Lioznov, M.
    Bacher, U.
    Blaise, D.
    Kroeger, N.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S248 - S248
  • [33] CD34+-Selected Stem Cell Boost without Further Conditioning for Poor Graft Function after Allogeneic Stem Cell Transplantation in Patients with Hematological Malignancies
    Klyuchnikov, Evgeny
    El-Cheikh, Jean
    Sputtek, Andreas
    Lioznov, Michael
    Calmels, Boris
    Furst, Sabine
    Chabannon, Christian
    Crocchiolo, Roberto
    Lemarie, Claude
    Faucher, Catherine
    Bacher, Ulrike
    Alchalby, Haefaa
    Stuebig, Thomas
    Wolschke, Christine
    Ayuk, Francis
    Reckhaus, Marie-Luise
    Blaise, Didier
    Kroeger, Nicolaus
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (03) : 382 - 386
  • [34] Role of Consolidation Therapy Prior to CD34-Selected Allogeneic Stem Cell Transplantation for Adult Patients with Acute Myeloid Leukemia in First Remission
    Berman, Ellin
    Assal, Amer
    Maloy, Molly
    Zheng, Junting
    Devlin, Sean M.
    Papadopoulos, Esperanza B.
    Jakubowski, Ann A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S311 - S312
  • [35] Treatment of graft failure after allogeneic haematopoietic cell transplantation with a booster of CD34-selected cells infused without conditioning
    Askaa, B.
    Fisher-Nielsen, A.
    Vindelov, L.
    Sengelov, H.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S187 - S188
  • [36] Allogeneic stem cell transplantation for sickle cell disease
    Robinson, Tara M.
    Fuchs, Ephraim J.
    CURRENT OPINION IN HEMATOLOGY, 2016, 23 (06) : 524 - 529
  • [37] Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation
    Holmberg, LA
    Boeckh, M
    Hooper, H
    Leisenring, W
    Rowley, S
    Heimfeld, S
    Press, O
    Maloney, DG
    McSweeney, P
    Corey, L
    Maziarz, RT
    Appelbaum, FR
    Bensinger, W
    BLOOD, 1999, 94 (12) : 4029 - 4035
  • [38] Vaccines are safe and effective after T-cell depleted CD34-selected allogeneic hematopoietic stem cell transplantation (Allo HCT)
    Malard, F.
    Shah, G. L.
    Seier, K.
    Cho, C.
    Devlin, S. M.
    Maloy, M.
    Borrill, T.
    Palazzo, M.
    van den Brink, M.
    Perales, M-A
    BONE MARROW TRANSPLANTATION, 2017, 52 : S29 - S29
  • [39] Individually adjusted prophylactic donor lymphocyte infusions after CD34-selected allogeneic peripheral blood stem cell transplantation
    C Ferrá
    M Rodríguez-Luaces
    D Gallardo
    M Encuentra
    GA Martín-Henao
    J Peris
    I Ancín
    J Sarrá
    JJ Berlanga
    J García
    A Grañena
    Bone Marrow Transplantation, 2001, 28 : 963 - 968
  • [40] Infectious complications after CD34-selected autologous peripheral blood stem cell transplantation
    Sica, S
    Salutari, P
    La Barbera, EO
    Sorà, F
    Piccirillo, N
    Leone, G
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 101 (03) : 592 - 593
12345